DiaMedica Announces Last Patient Out for Phase II Diabetes Trial
Posted on: Tuesday, 27 May 2008, 03:00 CDT
DiaMedica has announced the enrolment of the last patient in the Phase II proof of concept clinical trial of DM-83.
The study will evaluate DM-83s effectiveness at controlling blood sugar levels in type 2 diabetics after consuming a meal. The 20 patient trial will measure both changes in insulin and glucose as the study's primary endpoints with final results to be analyzed and released by early third quarter, 2008.
Rick Pauls, president and CEO of DiaMedica, said: "Patients will compare the effects of DM-83 to a placebo in this cross over study. In this regard, each individual will serve as their own control and therefore we will have a better idea as to how well DM-83 is able to manage a type 2 diabetic's blood sugar and insulin levels in the post prandial state."
Source: Datamonitor
Related Articles
- The State of Elementary Social Studies Teaching in One Urban District
- Portraits of Practices in Social Studies Methods Courses
- Impact of a High School Graduation Examination on Social Studies Teachers' Instructional Practices
- Brain Study Examines How People Feel Pain
- Ancient oceans lacked oxygen essential for life, study shows
- Blacks' DNA to Be Used in Disease Study
- Boeing Studies Keep ISS Humming
- Antidepressant Study Needs Mexican Volunteers
- Bear Study May Aid Osteoporosis Research
- Alzheimer's Studies Look at Role of Fats
 |
 |
User Comments (0)
RSS Feeds